Vanguard Group Inc Monte Rosa Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,988,953 shares of GLUE stock, worth $42.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,988,953
Previous 3,140,510 4.83%
Holding current value
$42.9 Million
Previous $14.2 Million 56.38%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$4.19 - $7.49 $635,023 - $1.14 Million
-151,557 Reduced 4.83%
2,988,953 $22.1 Million
Q2 2025

Aug 11, 2025
BUY
$3.7 - $5.33 $149,753 - $215,726
40,474 Added 1.31%
3,140,510 $14.2 Million
Q1 2025

May 09, 2025
SELL
$4.64 - $7.17 $261,315 - $403,800
-56,318 Reduced 1.78%
3,100,036 $14.4 Million
Q4 2024

Feb 11, 2025
BUY
$4.8 - $10.36 $2.99 Million - $6.45 Million
622,134 Added 24.55%
3,156,354 $21.9 Million
Q3 2024

Nov 13, 2024
SELL
$3.59 - $6.97 $46,149 - $89,599
-12,855 Reduced 0.5%
2,534,220 $13.4 Million
Q2 2024

Aug 13, 2024
BUY
$3.38 - $7.86 $3.08 Million - $7.16 Million
911,246 Added 55.71%
2,547,075 $9.53 Million
Q1 2024

May 10, 2024
BUY
$4.26 - $8.46 $201,975 - $401,105
47,412 Added 2.98%
1,635,829 $11.5 Million
Q4 2023

Feb 14, 2024
SELL
$2.5 - $5.93 $99,900 - $236,962
-39,960 Reduced 2.45%
1,588,417 $8.97 Million
Q3 2023

Nov 14, 2023
BUY
$4.78 - $7.22 $342,195 - $516,872
71,589 Added 4.6%
1,628,377 $7.8 Million
Q2 2023

Aug 14, 2023
BUY
$4.53 - $8.4 $495,373 - $918,573
109,354 Added 7.56%
1,556,788 $10.7 Million
Q1 2023

May 15, 2023
BUY
$5.95 - $8.21 $123,284 - $170,111
20,720 Added 1.45%
1,447,434 $11.3 Million
Q4 2022

Feb 10, 2023
BUY
$6.71 - $9.72 $127,805 - $185,136
19,047 Added 1.35%
1,426,714 $10.9 Million
Q3 2022

Nov 14, 2022
SELL
$7.17 - $12.16 $6.13 Million - $10.4 Million
-855,239 Reduced 37.79%
1,407,667 $11.5 Million
Q2 2022

Aug 12, 2022
SELL
$6.15 - $14.99 $4.55 Million - $11.1 Million
-739,866 Reduced 24.64%
2,262,906 $21.9 Million
Q1 2022

May 13, 2022
BUY
$10.36 - $20.41 $19.9 Million - $39.2 Million
1,922,156 Added 177.88%
3,002,772 $42.1 Million
Q4 2021

Feb 14, 2022
BUY
$16.28 - $27.15 $986,486 - $1.65 Million
60,595 Added 5.94%
1,080,616 $22.1 Million
Q3 2021

Nov 12, 2021
BUY
$18.59 - $42.21 $17.1 Million - $38.8 Million
920,021 Added 920.02%
1,020,021 $22.7 Million
Q2 2021

Aug 13, 2021
BUY
$18.86 - $22.7 $1.89 Million - $2.27 Million
100,000 New
100,000 $2.27 Million

Others Institutions Holding GLUE

# of Institutions
132
Shares Held
55.7M
Call Options Held
159K
Put Options Held
269K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $671M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email